| VRTX |
Vertex Pharmaceuticals Incorporated |
137.54b |
547.43 |
0.91% |
34.94 |
30.70% |
10.48% |
— |
| MRNA |
Moderna, Inc. |
96.40b |
253.57 |
5.02% |
— |
(110.46%) |
13.13% |
— |
| REGN |
Regeneron Pharmaceuticals, Inc. |
93.39b |
905.02 |
0.23% |
19.26 |
28.51% |
18.59% |
0.41% |
| ARGX |
argenex SE |
56.27b |
924.82 |
3.36% |
30.64 |
31.68% |
60.84% |
— |
| ONC |
BeOne Medicines Ltd. - Sponsored ADR |
40.38b |
406.26 |
4.91% |
68.86 |
13.86% |
32.86% |
— |
| RPRX |
Royalty Pharma PLC |
38.95b |
67.28 |
(0.43%) |
37.63 |
25.70% |
11.36% |
1.37% |
| RVMD |
Revolution Medicines, Inc. |
38.08b |
192.35 |
8.27% |
— |
(894.40%) |
491.12% |
— |
| GMAB |
Genmab A/S Sponsored ADR |
31.51b |
53.58 |
1.59% |
42.19 |
19.08% |
22.26% |
— |
| ROIV |
Roivant Sciences Ltd. |
26.45b |
38.90 |
6.23% |
— |
(3,534.96%) |
(67.58%) |
— |
| INCY |
Incyte Corporation |
24.05b |
119.22 |
1.03% |
56.81 |
6.71% |
24.88% |
— |
| INSM |
Insmed, Inc. |
23.86b |
114.36 |
5.15% |
— |
(39.85%) |
239.97% |
— |
| BNTX |
BioNTech SE Sponsored ADR |
21.57b |
87.19 |
1.55% |
— |
(63.77%) |
(22.73%) |
— |
| ALNY |
Alnylam Pharmaceuticals, Inc. |
20.98b |
156.28 |
(0.24%) |
7.89 |
52.85% |
56.17% |
— |
| EXEL |
Exelixis, Inc. |
16.77b |
69.55 |
1.22% |
20.08 |
35.45% |
9.12% |
— |
| ASND |
Ascendis Pharma A/S |
16.64b |
257.02 |
1.41% |
18.53 |
71.20% |
125.98% |
— |
| JAZZ |
Jazz Pharmaceuticals PLC |
14.59b |
235.25 |
3.49% |
64.65 |
4.36% |
13.48% |
— |
| BBIO |
BridgeBio Pharma, Inc. |
14.47b |
74.28 |
0.01% |
— |
(62.62%) |
167.27% |
— |
| HALO |
Halozyme Therapeutics, Inc. |
13.96b |
103.93 |
(15.48%) |
24.75 |
26.93% |
45.03% |
— |
| TECH |
Bio-Techne Corp |
11.41b |
72.79 |
0.18% |
66.17 |
14.00% |
0.94% |
0.44% |
| SMMT |
Summit Therapeutics PLC |
11.32b |
16.13 |
13.67% |
— |
0.00% |
(61.03%) |
— |
| KYMR |
Kymera Therapeutics, Inc. |
10.94b |
132.01 |
3.04% |
— |
0.00% |
134.84% |
— |
| BMRN |
BioMarin Pharmaceutical Inc. |
10.87b |
55.89 |
(0.41%) |
— |
(0.52%) |
18.14% |
— |
| PCVX |
Vaxcyte, Inc. |
9.75b |
63.82 |
3.07% |
— |
0.00% |
— |
— |
| MDGL |
Madrigal Pharmaceuticals, Inc. |
9.29b |
397.03 |
(0.77%) |
— |
(10.89%) |
92.80% |
— |
| SYRE |
Spyre Therapeutics, Inc. |
9.17b |
104.18 |
7.86% |
— |
0.00% |
(81.84%) |
— |
| KRYS |
Krystal Biotech, Inc. |
8.90b |
300.31 |
0.02% |
39.21 |
47.91% |
25.96% |
— |
| TGTX |
TG Therapeutics, Inc. |
8.87b |
59.60 |
2.79% |
19.61 |
55.22% |
76.08% |
— |
| PTGX |
Protagonist Therapeutics, Inc. |
8.75b |
131.81 |
(2.55%) |
108.04 |
29.40% |
34.81% |
— |
| IBRX |
ImmunityBio, Inc. |
8.49b |
8.67 |
8.24% |
— |
(598.56%) |
192.92% |
— |
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
8.12b |
58.01 |
0.96% |
— |
(47.79%) |
16.13% |
— |
| TWST |
Twist Bioscience Corporation |
7.94b |
119.38 |
(1.02%) |
— |
(31.66%) |
19.19% |
— |
| CORT |
Corcept Therapeutics Incorporated |
7.84b |
72.63 |
1.40% |
47.81 |
16.54% |
30.02% |
— |
| CYTK |
Cytokinetics, Incorporated |
7.72b |
53.84 |
(3.08%) |
— |
(686.63%) |
29.90% |
— |
| ABVX |
Abivax SA Sponsored ADR |
7.37b |
86.16 |
2.35% |
— |
0.00% |
— |
— |
| CAI |
Caris Life Sciences,�Inc. |
7.36b |
25.11 |
(3.53%) |
73.94 |
9.16% |
68.84% |
— |
| PRAX |
Praxis Precision Medicines, Inc. |
7.33b |
276.75 |
5.39% |
— |
0.00% |
249.53% |
— |
| RYTM |
Rhythm Pharmaceuticals, Inc. |
7.28b |
112.38 |
7.01% |
— |
(70.63%) |
61.04% |
— |
| AXSM |
Axsome Therapeutics, Inc. |
6.83b |
132.13 |
1.80% |
— |
(18.18%) |
54.16% |
— |
| IONS |
Ionis Pharmaceuticals, Inc. |
6.45b |
39.48 |
1.75% |
— |
(64.66%) |
(7.41%) |
— |
| ORKA |
Oruka Therapeutics, Inc. |
6.36b |
102.68 |
6.94% |
— |
0.00% |
— |
0.00% |
| MIRM |
Mirum Pharmaceuticals, Inc. |
6.11b |
93.82 |
0.30% |
— |
(134.75%) |
42.18% |
— |
| LGND |
Ligand Pharmaceuticals Incorporated |
5.98b |
306.43 |
2.48% |
118.18 |
20.27% |
1.03% |
— |
| IMVT |
Immunovant, Inc. |
5.86b |
30.53 |
7.54% |
— |
0.00% |
— |
— |
| BLTE |
Belite Bio, Inc. Sponsored ADR |
5.77b |
154.46 |
7.87% |
— |
0.00% |
— |
— |
| CGON |
CG Oncology, Inc. |
5.74b |
76.08 |
17.41% |
— |
(3,851.09%) |
178.12% |
— |
| KOD |
Kodiak Sciences Inc. |
5.72b |
98.85 |
8.60% |
— |
0.00% |
— |
— |
| SRRK |
Scholar Rock Holding Corporation |
5.54b |
46.94 |
3.16% |
— |
0.00% |
213.65% |
— |
| PTCT |
PTC Therapeutics, Inc. |
5.49b |
65.55 |
(0.18%) |
— |
(9.17%) |
(35.05%) |
— |
| MANE |
Veradermics Incorporated |
5.37b |
138.19 |
7.46% |
— |
0.00% |
— |
— |
| COGT |
Cogent Biosciences, Inc. |
5.13b |
31.60 |
6.83% |
— |
0.00% |
110.23% |
— |
| CRSP |
CRISPR Therapeutics AG |
4.71b |
49.92 |
2.80% |
— |
(1,812.07%) |
(34.34%) |
— |
| TVTX |
Travere Therapeutics, Inc. |
4.69b |
49.45 |
1.19% |
— |
(18.66%) |
49.38% |
— |
| ERAS |
Erasca, Inc. |
4.64b |
14.34 |
8.06% |
— |
0.00% |
— |
— |
| DNTH |
Dianthus Therapeutics, Inc. |
4.64b |
86.43 |
4.12% |
— |
(7,436.50%) |
(11.70%) |
— |
| LEGN |
Legend Biotech Corporation Sponsored ADR |
4.37b |
23.45 |
4.04% |
— |
(7.20%) |
59.55% |
— |
| EWTX |
Edgewise Therapeutics, Inc. |
4.22b |
44.89 |
15.49% |
4.85 |
0.00% |
— |
— |
| DFTX |
Definium Therapeutics, Inc. |
4.08b |
33.27 |
9.58% |
— |
0.00% |
— |
— |
| RLAY |
Relay Therapeutics, Inc. |
3.73b |
18.44 |
8.47% |
— |
0.00% |
(74.29%) |
— |
| ACAD |
ACADIA Pharmaceuticals Inc. |
3.66b |
21.23 |
(0.05%) |
9.97 |
30.13% |
14.82% |
— |
| XENE |
Xenon Pharmaceuticals Inc. |
3.65b |
39.00 |
3.50% |
— |
0.00% |
(8.15%) |
— |
| ABCL |
AbCellera Biologics Inc. |
3.61b |
11.89 |
6.83% |
— |
(248.82%) |
101.29% |
— |
| TNGX |
Tango Therapeutics, Inc. |
3.52b |
21.50 |
3.02% |
— |
0.00% |
48.29% |
— |
| IOVA |
Iovance Biotherapeutics, Inc. |
3.51b |
7.99 |
3.23% |
— |
(58.19%) |
51.34% |
— |
| IRON |
Disc Medicine, Inc. |
3.48b |
78.51 |
0.05% |
— |
0.00% |
— |
— |
| PBLS |
Parabilis Medicines, Inc. |
3.44b |
28.59 |
2.55% |
— |
0.00% |
— |
— |
| ARQT |
Arcutis Biotherapeutics, Inc. |
3.39b |
25.55 |
(5.37%) |
112.46 |
5.88% |
60.00% |
— |
| TARS |
Tarsus Pharmaceuticals, Inc. |
3.33b |
68.81 |
1.91% |
— |
(102.93%) |
86.34% |
— |
| VKTX |
Viking Therapeutics, Inc. |
3.29b |
26.82 |
3.99% |
— |
0.00% |
— |
— |
| ELVN |
Enliven Therapeutics, Inc. |
3.28b |
49.25 |
9.96% |
— |
0.00% |
— |
— |
| DYN |
Dyne Therapeutics, Inc. |
3.24b |
18.06 |
4.03% |
— |
0.00% |
— |
— |
| VRDN |
Viridian Therapeutics, Inc. |
3.23b |
28.50 |
(0.18%) |
— |
(1,724.06%) |
(62.83%) |
— |
| TLX |
Telix Pharmaceuticals Limited |
3.21b |
9.65 |
2.44% |
— |
— |
— |
— |
| DNLI |
Denali Therapeutics Inc. |
3.16b |
20.12 |
2.03% |
— |
(1,388.24%) |
(93.40%) |
— |
| CELC |
Celcuity, Inc. |
3.13b |
66.82 |
4.34% |
— |
0.00% |
— |
— |
| ADMA |
ADMA Biologics Inc |
2.96b |
12.80 |
(3.10%) |
16.14 |
35.14% |
6.26% |
— |
| IDYA |
IDEAYA Biosciences, Inc. |
2.96b |
31.20 |
1.79% |
— |
(1,149.62%) |
(83.64%) |
— |
| BEAM |
Beam Therapeutics Inc. |
2.68b |
26.34 |
1.82% |
— |
(73.78%) |
163.27% |
— |
| VCEL |
Vericel Corporation |
2.65b |
54.47 |
5.20% |
82.95 |
10.27% |
25.30% |
— |
| ZLAB |
Zai Lab Limited Unsponsored ADR |
2.55b |
25.40 |
12.39% |
— |
(44.91%) |
0.02% |
— |
| XNCR |
Xencor, Inc. |
2.53b |
35.81 |
5.17% |
— |
(58.79%) |
33.55% |
— |
| RCUS |
Arcus Biosciences, Inc. |
2.51b |
18.29 |
3.39% |
— |
(453.00%) |
(58.33%) |
— |
| MBX |
MBX Biosciences, Inc. |
2.33b |
51.27 |
5.80% |
— |
0.00% |
— |
— |
| PHVS |
Pharvaris N.V. |
2.28b |
34.51 |
6.09% |
— |
0.00% |
— |
— |
| PVLA |
Palvella Therapeutics, Inc. |
2.26b |
174.08 |
10.99% |
— |
0.00% |
146.67% |
— |
| NAMS |
NewAmsterdam Pharma Company N.V. |
2.26b |
19.02 |
0.69% |
— |
(789.94%) |
(26.41%) |
— |
| CLDX |
Celldex Therapeutics, Inc. |
2.22b |
29.90 |
5.77% |
— |
(33,883.77%) |
(88.27%) |
— |
| SEPN |
Septerna, Inc. |
2.21b |
48.95 |
3.38% |
— |
(24.51%) |
13,520.11% |
— |
| LKFT |
Lakefront Biotherapeutics - Sponsored ADR |
2.20b |
33.37 |
(0.57%) |
— |
(6.81%) |
(52.22%) |
— |
| RXRX |
Recursion Pharmaceuticals, Inc. |
2.18b |
3.52 |
0.57% |
— |
(697.13%) |
56.18% |
— |
| AUPH |
Aurinia Pharmaceuticals Inc |
2.17b |
16.42 |
1.30% |
6.87 |
97.68% |
21.04% |
— |
| VERA |
Vera Therapeutics, Inc. |
2.17b |
30.12 |
(0.07%) |
— |
0.00% |
— |
— |
| COAG |
Hemab Therapeutics Holdings, Inc. |
2.13b |
48.60 |
6.65% |
— |
0.00% |
— |
— |
| IMNM |
Immunome, Inc. |
2.11b |
18.65 |
4.13% |
— |
0.00% |
16.74% |
— |
| BHVN |
Biohaven Ltd. |
2.10b |
14.46 |
4.03% |
— |
0.00% |
425.20% |
— |
| ZYME |
Zymeworks Inc. |
2.04b |
29.52 |
2.71% |
— |
(404.00%) |
(69.78%) |
— |
| FTRE |
Fortrea Holdings Inc. |
1.97b |
21.95 |
7.28% |
— |
(2.58%) |
(3.38%) |
— |
| TRAX |
First Tracks Biotherapeutics, Inc. |
1.91b |
47.78 |
5.17% |
— |
0.00% |
— |
— |
| REPL |
Replimune Group, Inc. |
1.90b |
21.72 |
8.49% |
— |
0.00% |
— |
— |
| HRMY |
Harmony Biosciences Holdings, Inc. |
1.89b |
33.04 |
1.76% |
10.74 |
18.05% |
19.79% |
— |
| VIR |
Vir Biotechnology, Inc. |
1.86b |
12.19 |
10.62% |
— |
(61.03%) |
1,695.96% |
— |
stockrow